Leveraging Genomic Data to Transform Rare Cancer Treatment

Feb 28th is Rare Disease Day, a day dedicated to raising awareness of rare diseases, including rare cancers. These conditions are often overlooked compared to more commonly occurring cancers but did you know there are over 500 different rare cancers?

In the fight against cancer, understanding the genetic makeup is critical to developing personalized treatments that can make an actual difference in treating patients. A 2023 observational study1 presented in JAMA showed that only 6.8% underwent germline testing within two years of diagnosis. Furthermore, testing varied by cancer type, being the highest in males with breast cancer (50%) and in patients with ovarian cancer(38.6%). However, for many patients, especially those with rare cancer types, access to genomic sequencing, timely diagnosis and personalized care treatment protocols remain a significant challenge.

Join us during this time of rare disease awareness to explore how the Maine Cancer Genomics Initiative (MCGI) is revolutionizing cancer treatment for patients in rural and urban communities across Maine. Leveraging the data available in the Cancer Knowledgebase (CKB), MCGI enables clinicians to identify potential treatment options. CKB includes information on cancer related genes and variants, together with targeted therapies and clinical trials associated with genomic data. It also provides case study level data, based on national standardized guidelines thus equipping healthcare providers with the information they need to better understand rare cancer tumor types. Healthcare providers use these scientific and clinical insights to develop personalized treatment and improve outcomes for their patients.

In the webinar, you will learn:

• How limited access to personalized treatment impacts patients with rare cancer types
• Understand how Maine Cancer Genomics Initiative is using patients' genomic data, CKB and their collaboration to improve treatment outcomes
• Discover how you can access a wealth of data to make more informed and targeted decisions, improving patient outcomes and quality of life.

Interested in learning more? Get in touch with our team!
Schedule a call today: https://www.genomenon.com/schedule-di...